Currently, Neogen has a gross margin of 47.4%, an operating margin of -0.8%, an EBITDA margin of 12.7%, and a net margin of -6.3%; its operating margin is negative at -0.8%, and its net margin is negative at -6.3%. Operating margin had the largest improvement, expanding by 120.9 percentage points, while the other available margins also increased.
Neogen's margins averaged 48.19% gross, -38.08% operating, -21.97% EBITDA, and -41.09% net during the last 3 years. Neogen's current metrics show that operating, EBITDA, and net margins are above their three-year averages and gross margin is below its three-year average.
Gross margin expanded by 1 percentage point, operating margin by 120.9 percentage points, EBITDA margin by 111.9 percentage points, and net margin by 111.3 percentage points, led by operating margin with an increase of 120.9 percentage points.
Neogen recorded an average gross margin of 48.19% across the last 3 years. Neogen currently reports a gross margin of 47.4%, 0.8 percentage points below its three-year average. Over the last 3 years, Neogen's gross margin peaked at 51% in Feb 2024 and reached a low of 45.2% in Feb 2026.
Across the last 3 years, Neogen had an average operating margin of -38.08%. Against its three-year average, Neogen's operating margin is currently -0.8%, 37.3 percentage points above its three-year average. Looking back over the last 3 years, Neogen's operating margin reached 7.9% at its highest point in Nov 2023 and -121.7% at its lowest in Aug 2025.
The average EBITDA margin for Neogen was -21.97% over the last 3 years. As of the latest period, the current EBITDA margin for Neogen is 12.7%, 34.7 percentage points above its three-year average. The EBITDA margin for Neogen moved between -104.9% in May 2025 and 20.8% in Nov 2023.
Neogen's net margin averaged -41.09% across the past 3 years. Compared with its three-year average, Neogen's current net margin is -6.3% and is 34.8 percentage points above its three-year average. Over the last 3 years, Neogen's net margin peaked at 1.3% in Nov 2023 and reached a low of -122.1% in May 2025.
Neogen's gross margin of 47.4% is below the Healthcare sector, the industry and its peers average. Looking at its Healthcare sector average of 68.3%, Neogen's gross margin is 31% lower.
As of Aug 31, 2026, NEOG has a gross margin of 47.4%.
As of Aug 31, 2026, NEOG has a negative operating margin of -0.8%.
As of Aug 31, 2026, NEOG has an EBITDA margin of 12.7%.
As of Aug 31, 2026, NEOG has a net margin of -6.3%.
Looking back over 3 years, NEOG recorded average margins of 48.2% gross, -38.1% operating, -22.0% EBITDA, and -41.1% net.
Looking back across 5 years, NEOG reached 51% gross in Feb 2024, 14% operating in Nov 2021, 20.8% EBITDA in Nov 2023, and 11.3% net in Nov 2021.
Over this 5-year history, Neogen's margins fell as low as 45.2% gross in Feb 2026, -121.7% operating in Aug 2025, -104.9% EBITDA in May 2025, and -122.1% net in May 2025.